{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:52:57Z","timestamp":1767495177878,"version":"3.44.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bcp.2021.114459","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:00:06Z","timestamp":1612832406000},"page":"114459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Higher susceptibility to heme oxidation and lower protein stability of the rare \u03b11C517Y\u03b21 sGC variant associated with moyamoya syndrome"],"prefix":"10.1016","volume":"186","author":[{"given":"Iraida","family":"Sharina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Lezgyieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yekaterina","family":"Krutsenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9094-4165","authenticated-orcid":false,"given":"Emil","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.bcp.2021.114459_b0005","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1073\/pnas.0602544103","article-title":"Nitric oxide activation of guanylyl cyclase in cells revisited","volume":"103","author":"Roy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"51","key":"10.1016\/j.bcp.2021.114459_b0010","doi-asserted-by":"crossref","first-page":"22060","DOI":"10.1073\/pnas.1013147107","article-title":"Exquisite sensitivity to subsecond, picomolar nitric oxide transients conferred on cells by guanylyl cyclase-coupled receptors","volume":"107","author":"Batchelor","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0015","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.272.3.1747","article-title":"Permissive role of nitric oxide in endothelin-induced migration of endothelial cells","volume":"272","author":"Noiri","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1 Pt 1","key":"10.1016\/j.bcp.2021.114459_b0020","doi-asserted-by":"crossref","first-page":"C236","DOI":"10.1152\/ajpcell.1998.274.1.C236","article-title":"Podokinesis in endothelial cell migration: role of nitric oxide","volume":"274","author":"Noiri","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114459_b0025","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8567","key":"10.1016\/j.bcp.2021.114459_b0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2021.114459_b0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0021-9150(95)05563-C","article-title":"FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty","volume":"117","author":"Seki","year":"1995","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.bcp.2021.114459_b0040","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bcp.2021.114459_b0045","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1111\/nmo.12120","article-title":"Heme deficiency of soluble guanylate cyclase induces gastroparesis","volume":"25","author":"Cosyns","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"issue":"18","key":"10.1016\/j.bcp.2021.114459_b0050","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.0609778104","article-title":"Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase","volume":"104","author":"Friebe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"11","key":"10.1016\/j.bcp.2021.114459_b0055","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/j.1460-9568.2008.06285.x","article-title":"Concepts of neural nitric oxide-mediated transmission","volume":"27","author":"Garthwaite","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"25","key":"10.1016\/j.bcp.2021.114459_b0060","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1161\/CIRCULATIONAHA.111.078824","article-title":"Endothelial function","volume":"124","author":"Vita","year":"2011","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.bcp.2021.114459_b0065","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.108.835223","article-title":"Molecular insights and therapeutic targets for diabetic endothelial dysfunction","volume":"120","author":"Xu","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.109.890962","article-title":"Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice","volume":"121","author":"Groneberg","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2021.114459_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jsxm.2016.12.007","article-title":"Erectile dysfunction in heme-deficient nitric oxide-unresponsive soluble guanylate cyclase knock-in mice","volume":"14","author":"Decaluwe","year":"2017","journal-title":"J. Sex Med."},{"key":"10.1016\/j.bcp.2021.114459_b0080","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1038\/ncomms9482","article-title":"Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice","volume":"6","author":"Thoonen","year":"2015","journal-title":"Nat. Commun."},{"issue":"7367","key":"10.1016\/j.bcp.2021.114459_b0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2021.114459_b0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ng.2337","article-title":"Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease","volume":"44","author":"Lu","year":"2012","journal-title":"Nat. Genet."},{"issue":"7480","key":"10.1016\/j.bcp.2021.114459_b0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","article-title":"Loss of alpha1beta1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia","volume":"94","author":"Herve","year":"2014","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2021.114459_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cge.12739","article-title":"Disrupted Nitric Oxide Signaling due to GUCY1A3 Mutations Increases Risk for Moyamoya Disease, Achalasia and Hypertension","volume":"90","author":"Wallace","year":"2016","journal-title":"Clinicla Genetics"},{"issue":"6","key":"10.1016\/j.bcp.2021.114459_b0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI27657","article-title":"Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system","volume":"116","author":"Mergia","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.111.186957","article-title":"Cobinamides are novel co-activators of NO receptor which target sGC catalytic domain","volume":"340","author":"Sharina","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2021.114459_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13055","article-title":"The fibrate gemfibrozil is an NO \u2013 and heme-independent activator of soluble guanylyl cyclase: in vitro studies","author":"Sharina","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114459_b0125","doi-asserted-by":"crossref","first-page":"H1565","DOI":"10.1152\/ajpheart.00222.2014","article-title":"Alternative splicing impairs sGC function in aortic aneurysm","volume":"307","author":"Martin","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"22","key":"10.1016\/j.bcp.2021.114459_b0130","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1074\/jbc.M710269200","article-title":"Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity","volume":"283","author":"Sharina","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7777","key":"10.1016\/j.bcp.2021.114459_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","article-title":"Structural insights into the mechanism of human soluble guanylate cyclase","volume":"574","author":"Kang","year":"2019","journal-title":"Nature"},{"issue":"W1","key":"10.1016\/j.bcp.2021.114459_b0140","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.bcp.2021.114459_b0145","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1073\/pnas.1633590100","article-title":"A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation","volume":"100","author":"Martin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2021.114459_b0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-540-68964-5_14","article-title":"NO- and haem-independent soluble guanylate cyclase activators","volume":"191","author":"Schmidt","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"29","key":"10.1016\/j.bcp.2021.114459_b0155","doi-asserted-by":"crossref","first-page":"22651","DOI":"10.1074\/jbc.M110.111559","article-title":"Structure of cinaciguat (BAY 58\u20132667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase","volume":"285","author":"Martin","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114459_b0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","article-title":"Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2021.114459_b0165","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.231486198","article-title":"YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components","volume":"98","author":"Martin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2021.114459_b0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.phrs.2016.06.029","article-title":"Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide","volume":"111","author":"Zhou","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"26","key":"10.1016\/j.bcp.2021.114459_b0175","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1021\/bi200794c","article-title":"Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta","volume":"50","author":"Fritz","year":"2011","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2021.114459_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.109.198234","article-title":"Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation","volume":"105","author":"Meurer","year":"2009","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2021.114459_b0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ncb836","article-title":"Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism","volume":"4","author":"Bota","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114459_b0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-801415-8.00012-6","article-title":"Measurement of ROS homeostasis in isolated mitochondria","volume":"547","author":"Tretter","year":"2014","journal-title":"Methods Enzymol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114459_b0195","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2021.114459_b0200","unstructured":"C.A.D. Consortium, et al., Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet., 45 (1) (2013) 25-33."},{"issue":"7537","key":"10.1016\/j.bcp.2021.114459_b0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2021.114459_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00395-016-0570-5","article-title":"Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants","volume":"111","author":"Wobst","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114459_b0215","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4103\/0028-3886.299171","article-title":"Moyamoya Disease 6 with Achalasia Due to GUCY1A3 Mutation in a Child","volume":"68","author":"Ramesh","year":"2020","journal-title":"Neurol. India"},{"issue":"5","key":"10.1016\/j.bcp.2021.114459_b0220","doi-asserted-by":"crossref","first-page":"H597","DOI":"10.1152\/ajpheart.00138.2012","article-title":"Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model","volume":"303","author":"Crassous","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"29","key":"10.1016\/j.bcp.2021.114459_b0225","doi-asserted-by":"crossref","first-page":"20734","DOI":"10.1016\/S0021-9258(19)36747-X","article-title":"IMP dehydrogenase inhibitors reduce intracellular tetrahydrobiopterin levels through reduction of intracellular GTP levels. Indications of the regulation of GTP cyclohydrolase I activity by restriction of GTP availability in the cells","volume":"267","author":"Hatakeyama","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2021.114459_b0230","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0006-2952(90)90420-P","article-title":"Transphosphorylation and G protein activation","volume":"39","author":"Otero","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0167-4781(00)00211-6","article-title":"Cloning and functional expression of the rat alpha(2) subunit of soluble guanylyl cyclase","volume":"1494","author":"Koglin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0240","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.111.186957","article-title":"Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain","volume":"340","author":"Sharina","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2021.114459_b0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphys.2018.00125","article-title":"Erythrocytes and Vascular Function: Oxygen and Nitric Oxide","volume":"9","author":"Helms","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2021.114459_b0250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0076-6879(05)96040-0","article-title":"Soluble Guanylyl Cyclase: The Nitric Oxide Receptor","volume":"396PE","author":"Martin","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2021.114459_b0255","article-title":"A \u201cSliding Scale Rule\u201d for Selectivity among NO, CO, and O(2) by Heme Protein Sensors","author":"Tsai","year":"2011","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0260","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/bi0489208","article-title":"Resonance Raman Evidence for the Presence of Two Heme Pocket Conformations with Varied Activities in CO-Bound Bovine Soluble Guanylate Cyclase and Their Conversion","volume":"44","author":"Li","year":"2005","journal-title":"Biochemistry"},{"issue":"37","key":"10.1016\/j.bcp.2021.114459_b0265","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.1073\/pnas.0506289102","article-title":"Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP","volume":"102","author":"Cary","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.bcp.2021.114459_b0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/bbrc.1997.7470","article-title":"Dissociation of nitric oxide from soluble guanylate cyclase","volume":"239","author":"Kharitonov","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"50","key":"10.1016\/j.bcp.2021.114459_b0275","doi-asserted-by":"crossref","first-page":"43182","DOI":"10.1074\/jbc.M111.290304","article-title":"Dynamic Ligand Exchange in Soluble Guanylyl Cyclase (sGC): IMPLICATIONS FOR sGC REGULATION AND DESENSITIZATION","volume":"286","author":"Tsai","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2021.114459_b0280","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1073\/pnas.1400711111","article-title":"Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase","volume":"111","author":"Campbell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1432-1033.1990.tb19276.x","article-title":"Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion","volume":"192","author":"Brune","year":"1990","journal-title":"Eur. J. Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2021.114459_b0290","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0891-5849(01)00706-7","article-title":"The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase","volume":"31","author":"Weber","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/ars.2016.6687","article-title":"The Role of Reactive Oxygen and Nitrogen Species in the Expression and Splicing of Nitric Oxide Receptor","volume":"26","author":"Sharina","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"10.1016\/j.bcp.2021.114459_b0300","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bcp.2021.114459_b0305","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjp.0707179","article-title":"Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species","volume":"150","author":"Gerassimou","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114459_b0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114459_b0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.117.310705","article-title":"Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling","volume":"121","author":"Rahaman","year":"2017","journal-title":"Circ. Res."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2021.114459_b0320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00726-003-0014-z","article-title":"Dityrosine as a product of oxidative stress and fluorescent probe","volume":"25","author":"Malencik","year":"2003","journal-title":"Amino Acids"},{"issue":"11","key":"10.1016\/j.bcp.2021.114459_b0325","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/ars.2012.4595","article-title":"Tyrosine modifications in aging","volume":"17","author":"Feeney","year":"2012","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"10.1016\/j.bcp.2021.114459_b0330","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1016\/S0021-9258(18)52938-0","article-title":"Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome","volume":"268","author":"Giulivi","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"51","key":"10.1016\/j.bcp.2021.114459_b0335","doi-asserted-by":"crossref","first-page":"43053","DOI":"10.1074\/jbc.M112.393892","article-title":"Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide","volume":"287","author":"Fernhoff","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114459_b0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00395-011-0160-5","article-title":"Regulation of vascular guanylyl cyclase by endothelial nitric oxide-dependent posttranslational modification","volume":"106","author":"Oppermann","year":"2011","journal-title":"Basic Res. Cardiol."},{"issue":"30","key":"10.1016\/j.bcp.2021.114459_b0345","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"10.1016\/j.bcp.2021.114459_b0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCRESAHA.108.175133","article-title":"Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance","volume":"103","author":"Sayed","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2021.114459_b0355","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jprot.2016.02.009","article-title":"Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor","volume":"138","author":"Beuve","year":"2016","journal-title":"J. Proteomics"},{"issue":"3","key":"10.1016\/j.bcp.2021.114459_b0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2015.6591","article-title":"Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor","volume":"26","author":"Beuve","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bcp.2021.114459_b0365","article-title":"Selective cysteines oxidation in soluble guanylyl cyclase catalytic domain is involved in NO activation","author":"Alapa","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"20","key":"10.1016\/j.bcp.2021.114459_b0370","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114459_b0375","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.chest.2016.05.024","article-title":"Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension","volume":"151","author":"Ghofrani","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2021.114459_b0380","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_249","article-title":"Soluble Guanylate Cyclase Stimulators and Activators","author":"Sandner","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114459_b0385","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.105.018747","article-title":"Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase","volume":"69","author":"Schindler","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114459_b0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.bcp.2021.114459_b0395","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:28:07Z","timestamp":1757770087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":79,"alternative-id":["S0006295221000551"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114459","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher susceptibility to heme oxidation and lower protein stability of the rare \u03b11C517Y\u03b21 sGC variant associated with moyamoya syndrome","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114459"}}